I’ll be presenting a cancer patient’s view on participating in a clinical trial at this healthcare conference. Our session, “Patient Centered Initiatives in Clinical Trial Design and Execution,” will be led by Mary Elmer, Executive Director of Patient Insights for Oncology at Merck, and will include patient tools developed by TransCelerate BioPharma.
The conference is now virtual and some sessions are live, others recorded. All are available for viewing at home.
DIA is an organization that brings life science professionals to interact with peers and patients through conferences throughout the world. It was originally founded by a group of pharmaceutical executives and academics around the controversy surrounding the drug Thalidomide.